Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RAD001 With Docetaxel and Bevacizumab in Metastatic Androgen Independent Prostate Cancer
NCT00574769Phase 2Completed
- Sponsor
- University of Southern California
- Start
- Feb 2010
- Primary completion
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of everolimus in prostate cancer (PCa), sponsored by University of Southern California. Started Feb 2010; status: completed.
02
Drugs
everolimus
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00574769.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00574769.